Active Substance & Generic Molecule Directory

Oxytetracycline Dihydrate in Malaysia: Registered Brands, Dosages & Price Comparison

Directory of all approved pharmaceutical brands containing Oxytetracycline Dihydrate registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).

13
Registered Brands
Availability in Malaysia:
Showing 13 of 13 registered brands
MAL Reg NoBrand Formulation NameStrength / DosageClassificationRegistration HolderAction
MAL19086010HALimoxin 200mg/ml LA Solution for Injection217.6 mg/mLVeterinary (MAL-V)Danberg (m) Sdn BhdCompare →
MAL23076022HACOM-200 20% w/w Premix222.20 gm 1 kgVeterinary (MAL-V)Sunzen Corporation Sdn BhdCompare →
MAL14070080HAOXITETRACICLINA 200mg/ml L.A. Solution for Injection215.6 mgVeterinary (MAL-V)Taseen Trading Sdn BhdCompare →
MAL12070028HAOXY 200g/kg Premix21.56 % (W/W)Veterinary (MAL-V)Life Biopharma Sdn. Bhd.Compare →
MAL18046025HACOXYCEN 200MG/ML SOLUTION FOR INJECTION216 mg 1.0 mlVeterinary (MAL-V)F.E. VENTURE SDN. BHD.Compare →
MAL25116063HAOXYFEED 200G/KG POWDER216 gmVeterinary (MAL-V)RANGE PHARMA SDN. BHD.Compare →
MAL18086148HACOXYTETRAVET 50%W/W PREMIX POWDER540 mg 1 gVeterinary (MAL-V)Lim Seng Pharmachem Sdn BhdCompare →
MAL18056078HACPF OXYTETRACYCLINE PREMIX 20% W/W POWDER215.65 mg 1 gVeterinary (MAL-V)Panfast Marketing (m) Sdn BhdCompare →
MAL17106057HASG. Oxytetra LA 20% (w/v) Solution220mg/mlVeterinary (MAL-V)Sunzen Corporation Sdn BhdCompare →
MAL13070026HASUPRACIN L.A. 20% Injection215.65 gVeterinary (MAL-V)RANGE PHARMA SDN. BHD.Compare →
MAL15070030HATM 200 gm / kg powder206.0 gVeterinary (MAL-V)Phibro Corporation (m) Sdn BhdCompare →
MAL15070028HACTM-400 gram/kg powder411.9 gVeterinary (MAL-V)Phibro Corporation (m) Sdn BhdCompare →
MAL20026084HAVime O.T.C 20%w/v L.A Solution for Injection216 mg 1 mlVeterinary (MAL-V)Vemedim Sdn BhdCompare →

Generic Bioequivalence & Drug Substitution in Malaysia

Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.